Clinical Trials Browser

Pancreatic Neoplasms × zolbetuximab × 1 year × Clear all

NCT03816163 2026-03-12

A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms